UPC CFI 624/2025
Jul 4, 2025·EP4344633: ANALYTE SENSOR METHODS
- Case details
- StatusCase ClosedActionProvisional measuresCategoryProvisional Measures
- Parties
- Division
- The Hague LD
- Technology
- Pharmaceutical & Medical
- Language
- English
- First decided
- Oct 17, 2025
- 2025-10-17PI grantedPreliminary injunctionApplication for provisional measures
The Hague Local Division granted Abbott Diabetes Care a preliminary injunction against Sinocare and A.Menarini Diagnostics regarding infringement of continuous glucose monitoring patent EP 4 344 633 (FreeStyle Libre technology), including information orders and delivery-up of infringing GlucoMen iCan products.
Legal issues:Preliminary injunction (continuous glucose monitoring)Claim construction of timeline graph featureProportionality of measures
| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-03-30 | Not public |
| Cover sheet | 2026-03-30 | Not public |
| Application document Claimant | 2026-03-30 | Not public |
| action.communication.general | 2025-11-14 | Not public |
| action.communication.general | 2025-11-05 | Not public |
| action.phaseChange.caseClose | 2025-10-23 | Not public |
| action.publishOrderDecision.order | 2025-10-17 | Not public |
| action.issueDecision.decision | 2025-10-17 | Not public |
| Final Order | 2025-10-17 | Public |
| action.phaseChange.oralPhaseClose | 2025-10-14 | Not public |
| ORAL_HEARING_REFERENCING_32414_2025_OH_HAG_LOC_UPC2025090309am | 2025-09-10 | Not public |
| ORAL_HEARING_REFERENCING_32414_2025_OH_HAG_LOC_UPC2025090309am | 2025-09-10 | Not public |
| Summon-Oral-Hearing | 2025-08-31 | Not public |
| Annex E3 | 2025-08-25 | Not public |
| Reply to the Objection EP 633 | 2025-08-25 | Not public |
| Opportunity to upload response and OH agenda | 2025-08-21 | Public |
| Acknowledgement-of-lodging | 2025-08-19 | Not public |
| Objection to Application | 2025-08-19 | Not public |
| Acknowledgement-of-lodging | 2025-08-19 | Not public |
| Exhibit BB26 | 2025-08-19 | Not public |
| Exhibit BB38 | 2025-08-19 | Not public |
| Exhibit BB02 | 2025-08-19 | Not public |
| Exhibit BB15 | 2025-08-19 | Not public |
| Exhibit BB05 | 2025-08-19 | Not public |
| Exhibit BB21 | 2025-08-19 | Not public |
| Exhibit BB17 | 2025-08-19 | Not public |
| Exhibit BB39 | 2025-08-19 | Not public |
| Exhibit BB07 | 2025-08-19 | Not public |
| Exhibit BB41 | 2025-08-19 | Not public |
| Exhibit BB14 | 2025-08-19 | Not public |
| Exhibit BB08D | 2025-08-19 | Not public |
| Exhibit BB33C | 2025-08-19 | Not public |
| Exhibit BB32 | 2025-08-19 | Not public |
| Exhibit BB29 | 2025-08-19 | Not public |
| Exhibit BB30 | 2025-08-19 | Not public |
| Exhibit BB24 | 2025-08-19 | Not public |
| Exhibit BB19 | 2025-08-19 | Not public |
| Exhibit BB03 | 2025-08-19 | Not public |
| Exhibit BB33D | 2025-08-19 | Not public |
| Exhibit BB07 | 2025-08-19 | Not public |
| Exhibit BB34A | 2025-08-19 | Not public |
| Exhibit BB06 | 2025-08-19 | Not public |
| Exhibit BB12 | 2025-08-19 | Not public |
| Exhibit BB37 | 2025-08-19 | Not public |
| Exhibit BB20 | 2025-08-19 | Not public |
| Exhibit BB16 | 2025-08-19 | Not public |
| Exhibit BB22 | 2025-08-19 | Not public |
| Exhibit BB33B | 2025-08-19 | Not public |
| Exhibit BB31A | 2025-08-19 | Not public |
| Exhibit BB28 | 2025-08-19 | Not public |
| Exhibit BB08A | 2025-08-19 | Not public |
| Exhibit BB28 | 2025-08-19 | Not public |
| Exhibit BB08B | 2025-08-19 | Not public |
| Exhibit BB08C | 2025-08-19 | Not public |
| Exhibit BB40 | 2025-08-19 | Not public |
| Exhibit BB18 | 2025-08-19 | Not public |
| Exhibit BB10 | 2025-08-19 | Not public |
| Exhibit BB23 | 2025-08-19 | Not public |
| Exhibit BB13 | 2025-08-19 | Not public |
| Exhibit BB33A | 2025-08-19 | Not public |
| Objection Abbott v Sinocare and Menarini EP633 PI | 2025-08-19 | Not public |
| Exhibit BB27 | 2025-08-19 | Not public |
| Exhibit BB01 | 2025-08-19 | Not public |
| Exhibit BB09 | 2025-08-19 | Not public |
| Exhibit BB04 | 2025-08-19 | Not public |
| Exhibit BB34B | 2025-08-19 | Not public |
| Exhibit BB31B | 2025-08-19 | Not public |
| Exhibit BB35A | 2025-08-19 | Not public |
| Exhibit BB11 | 2025-08-19 | Not public |
| Exhibit BB36 | 2025-08-19 | Not public |
| Exhibit BB29 | 2025-08-19 | Not public |
| Exhibit BB25 | 2025-08-19 | Not public |
| Exhibit BB35B | 2025-08-19 | Not public |
| Exhibit BB04 | 2025-08-18 | Not public |
| Exhibit BB13 | 2025-08-18 | Not public |
| Exhibit BB12 | 2025-08-18 | Not public |
| Exhibit BB11 | 2025-08-18 | Not public |
| Exhibit BB15 | 2025-08-18 | Not public |
| Exhibit BB40 | 2025-08-18 | Not public |
| Exhibit BB18 | 2025-08-18 | Not public |
| Formal response to the Order of the Court Objection EP633 | 2025-08-18 | Not public |
| Exhibit BB05 | 2025-08-18 | Not public |
| Exhibit BB16 | 2025-08-18 | Not public |
| Exhibit BB25 | 2025-08-18 | Not public |
| Exhibit BB24 | 2025-08-18 | Not public |
| Exhibit BB31B | 2025-08-18 | Not public |
| Exhibit BB33D | 2025-08-18 | Not public |
| Exhibit BB31A | 2025-08-18 | Not public |
| Exhibit BB17 | 2025-08-18 | Not public |
| Exhibit BB27 | 2025-08-18 | Not public |
| Exhibit BB03 | 2025-08-18 | Not public |
| Exhibit BB35A | 2025-08-18 | Not public |
| Exhibit BB23 | 2025-08-18 | Not public |
| Exhibit BB33C | 2025-08-18 | Not public |
| Exhibit BB21 | 2025-08-18 | Not public |
| Exhibit BB39 | 2025-08-18 | Not public |
| Exhibit BB01 | 2025-08-18 | Not public |
| Exhibit BB22 | 2025-08-18 | Not public |
| Exhibit BB29 | 2025-08-18 | Not public |
| Exhibit BB34B | 2025-08-18 | Not public |
| Exhibit BB38 | 2025-08-18 | Not public |
| Exhibit BB28 | 2025-08-18 | Not public |
| Exhibit BB07 | 2025-08-18 | Not public |
| Exhibit BB32 | 2025-08-18 | Not public |
| Exhibit BB08A | 2025-08-18 | Not public |
| Exhibit BB20 | 2025-08-18 | Not public |
| Exhibit BB35B | 2025-08-18 | Not public |
| Exhibit BB10 | 2025-08-18 | Not public |
| Exhibit BB29 | 2025-08-18 | Not public |
| Exhibit BB14 | 2025-08-18 | Not public |
| Exhibit BB09 | 2025-08-18 | Not public |
| Exhibit BB08C | 2025-08-18 | Not public |
| Exhibit BB34A | 2025-08-18 | Not public |
| Exhibit BB30 | 2025-08-18 | Not public |
| Exhibit BB08D | 2025-08-18 | Not public |
| Exhibit BB41 | 2025-08-18 | Not public |
| Exhibit BB06 | 2025-08-18 | Not public |
| Exhibit BB37 | 2025-08-18 | Not public |
| Exhibit BB02 | 2025-08-18 | Not public |
| Exhibit BB07 | 2025-08-18 | Not public |
| Exhibit BB33A | 2025-08-18 | Not public |
| Exhibit BB19 | 2025-08-18 | Not public |
| Exhibit BB36 | 2025-08-18 | Not public |
| Exhibit BB26 | 2025-08-18 | Not public |
| Exhibit BB28 | 2025-08-18 | Not public |
| Exhibit BB33B | 2025-08-18 | Not public |
| Exhibit BB08B | 2025-08-18 | Not public |
| Objection to Application | 2025-08-18 | Not public |
| completing workfow | 2025-08-15 | Public |
| completing workfow | 2025-08-15 | Public |
| Notification Of Service | 2025-08-07 | Not public |
| 2025_08_05 Confirmation of Service ACT_32414_2025 UPC_CFI_624_2025 Sinocare Inc | 2025-08-07 | Not public |
| Acknowledgement of access to case | 2025-08-05 | Not public |
| Outcome of the Order | 2025-08-01 | Not public |
| R.9 order | 2025-08-01 | Public |
| Template-Order | 2025-08-01 | Not public |
| Annex 3 | 2025-07-30 | Not public |
| Annex 5 | 2025-07-30 | Not public |
| Annex 2 | 2025-07-30 | Not public |
| Annex 6 | 2025-07-30 | Not public |
| Annex 1 | 2025-07-30 | Not public |
| Annex 4 | 2025-07-30 | Not public |
| Comments pursuant to RoP264 | 2025-07-30 | Not public |
| Panel-Appointment | 2025-07-30 | Not public |
| opportunity to comment | 2025-07-29 | Not public |
| Receipt | 2025-07-29 | Not public |
| Rule 9 Application | 2025-07-28 | Not public |
| Acknowledgement of access to case | 2025-07-28 | Not public |
| Letter-for-Service | 2025-07-18 | Not public |
| Notification Of Service | 2025-07-17 | Not public |
| 20250716 ACT_32414_2025 UPC_CFI_624_2025 Confirmation of service | 2025-07-17 | Not public |
| Letter-for-Service | 2025-07-14 | Not public |
| Panel-Appointment | 2025-07-10 | Not public |
| Notice-to-Accompany-Service-of-Order-for-Measures | 2025-07-09 | Not public |
| Notice-to-Accompany-Service-of-Order-for-Measures | 2025-07-09 | Not public |
| Panel-Appointment | 2025-07-09 | Not public |
| Application-For-Measures-Receipt | 2025-07-09 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-09 | Not public |
| Annex E2 - part 2 (incl JK-1 to JK-10) | 2025-07-08 | Not public |
| Annex C1 | 2025-07-08 | Not public |
| Formal response to the request for amendments | 2025-07-08 | Not public |
| Annex D4 | 2025-07-08 | Not public |
| Annex D6 | 2025-07-08 | Not public |
| Annex D7 | 2025-07-08 | Not public |
| Annex B1 | 2025-07-08 | Not public |
| Annex B2 | 2025-07-08 | Not public |
| Annex E1 | 2025-07-08 | Not public |
| Annex A1 | 2025-07-08 | Not public |
| Annex D1 | 2025-07-08 | Not public |
| Annex D3 | 2025-07-08 | Not public |
| Annex D5 | 2025-07-08 | Not public |
| Annex E2 - part 1 (incl JK-1) | 2025-07-08 | Not public |
| Application for Provisional Measures | 2025-07-08 | Not public |
| Annex D2 | 2025-07-08 | Not public |
| Formal-checks_Request-for-correction | 2025-07-08 | Not public |
| Application-For-Measures-Acknowledgement | 2025-07-08 | Not public |
| Annex D2 | 2025-07-08 | Not public |
| Annex E2 - part 2 (incl JK-1 to JK-10) | 2025-07-08 | Not public |
| Annex B2 | 2025-07-08 | Not public |
| Annex D5 | 2025-07-08 | Not public |
| Annex D7 | 2025-07-08 | Not public |
| Annex E1 | 2025-07-08 | Not public |
| Annex B1 | 2025-07-08 | Not public |
| Annex C1 | 2025-07-08 | Not public |
| Annex D3 | 2025-07-08 | Not public |
| Annex D4 | 2025-07-08 | Not public |
| Annex D6 | 2025-07-08 | Not public |
| Annex A1 | 2025-07-08 | Not public |
| Annex D1 | 2025-07-08 | Not public |
| Application for Provisional Measures | 2025-07-08 | Not public |
| Annex E2 - part 1 (incl JK-1) | 2025-07-08 | Not public |
Abbott Diabetes Care obtained a preliminary injunction from The Hague Local Division against Sinocare and A. Menarini Diagnostics prohibiting the GlucoMen iCan CGM system across all UPC territories for infringement of EP 4 344 633 (FreeStyle Libre analyte sensor technology). The court also ordered delivery-up of infringing products and disclosure of distribution channels, but rejected Abbott's request for a customs-goods declaration under EU Regulation 608/2013 as unavailable in PI proceedings, and limited the information order to distribution data rather than financial figures.
GlucoMen iCan infringes EP 4 344 633 covering continuous glucose monitoring sensor technology
ClaimantLegal basis: Art. 62 UPCA; R. 211 RoPNote: The Hague Local Division found infringement sufficiently demonstrated for PI purposes and granted the injunction across all UPC member states.
Defendants should not be ordered to comply jointly and severally as independent companies
RespondentNote: Court agreed that Sinocare and Menarini are independent companies and did not impose joint and several liability for the substantive injunction obligations.
Declaration that GlucoMen iCan is 'goods suspected of infringing an IP right' under EU Regulation 608/2013 should be granted as a provisional measure
ClaimantLegal basis: Art. 2(7)(a) of Regulation (EU) No 608/2013Reason: Court held that such a declaration is not available as a provisional measure regardless of the merits.
Information order should include price, sales numbers, and cost data
ClaimantLegal basis: R. 211 RoPReason: Court found that financial data is only relevant for damages calculation which is premature at the PI stage; the information order was limited to distribution channels and product origins.
Information disclosure should be subject to confidentiality
RespondentReason: Court rejected confidentiality request given the limited scope of the ordered information disclosure.
Browse other cases on this principle.